cholestyramine resin has been researched along with Impotence in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cambria, R; Cattani, F; De Cobelli, O; Fodor, C; Garibaldi, C; Gerardi, MA; Jereczek-Fossa, BA; Matei, DV; Maucieri, A; Musi, G; Orecchia, R; Santoro, L; Vavassori, A; Vischioni, B; Zerini, D | 1 |
| Hanefeld, M | 1 |
2 other study(ies) available for cholestyramine resin and Impotence
| Article | Year |
|---|---|
Reporting combined outcomes with Trifecta and survival, continence, and potency (SCP) classification in 337 patients with prostate cancer treated with image-guided hypofractionated radiotherapy.
Topics: Aged; Androgen Antagonists; Cholestyramine Resin; Disease-Free Survival; Dose Fractionation, Radiation; Erectile Dysfunction; Humans; Longitudinal Studies; Male; Middle Aged; Models, Biological; Penile Erection; Prospective Studies; Prostatic Neoplasms; Radiotherapy, Image-Guided; Treatment Outcome; Urinary Incontinence; Urination | 2014 |
[Drug treatment of hyperlipoproteinemias].
Topics: Cholestasis; Cholestyramine Resin; Clofibrate; Colestipol; Erectile Dysfunction; Female; Humans; Hyperlipidemias; Male; Nicotinic Acids | 1977 |